comparemela.com

Latest Breaking News On - Institutional family asset management - Page 5 : comparemela.com

ICW Investment Advisors LLC Purchases 41 Shares of FactSet Research Systems Inc. (NYSE:FDS)

ICW Investment Advisors LLC Purchases 41 Shares of FactSet Research Systems Inc. (NYSE:FDS)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Asia-pacific
Gregoryt-moskoff
Investment-advisors
Institutional-family-asset-management
Wolfe-research
Factset-research-systems-inc
Barclays
Royal-bank
News-ratings-for-factset-research-systems-daily
Quarter-for-factset-research-systems
Securities-exchange-commission

Hyliion Holdings Corp. (NYSE:HYLN) Sees Significant Increase in Short Interest

Hyliion Holdings Corp. (NYSE:HYLN) Sees Significant Increase in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Institutional-family-asset-management
Hyliion-holdings-corp
Sg-americas-securities
Mitsubishi-ufj
Capital-partners
Kokusai-asset-management-co
Hyliion-holdings
Get-free-report
Asset-management
Family-asset-management
Hyliion-daily

Gilead Sciences (NASDAQ:GILD) Given New $74.00 Price Target at Royal Bank of Canada

Gilead Sciences (NASDAQ:GILD – Free Report) had its target price lowered by Royal Bank of Canada from $76.00 to $74.00 in a research note issued to investors on Friday morning, Benzinga reports. The brokerage currently has a sector perform rating on the biopharmaceutical company’s stock. A number of other research analysts also recently issued reports […]

Canada
United-states
Complera-eviplera
Merdad-parsey
Nilsine-partners
Gilead-sciences
Gilead-sciences-inc
News-ratings-for-gilead-sciences-daily
Gilead-sciences-company-profile
Gilead-sciences-trading
Institutional-investors-weigh-in-on-gilead-sciences
Barclays

Marco Investment Management LLC Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Marco Investment Management LLC lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 25,937 shares of the biopharmaceutical company’s stock after purchasing an additional 251 shares during the quarter. Marco Investment Management […]

United-states
Merdad-parsey
Complera-eviplera
Gilead-sciences-price-performance
Gilead-sciences
Wealth-partners
Nilsine-partners
Financial-counselors-inc
Nasdaq
Etesian-wealth-advisors-inc
Securities-exchange-commission
Marco-investment-management

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Position Cut by Meritage Portfolio Management

Meritage Portfolio Management lessened its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 65,558 shares of the biopharmaceutical company’s stock after selling 342 shares during the […]

United-states
Merdad-parsey
Complera-eviplera
Gilead-sciences-inc
Morgan-stanley
News-ratings-for-gilead-sciences-daily
Etesian-wealth-advisors-inc
Nasdaq
Nilsine-partners
Institutional-family-asset-management
Securities-exchange-commission
Gilead-sciences-price-performance

vimarsana © 2020. All Rights Reserved.